Tariffs are raising the prices Americans pay for wheelchairs
Experts say medical supply chain disruptions put Americans’ health at risk.
As of the end of 2024, an estimated 5.5 million Americans used wheelchairs to get around, and the need is growing as the population ages. Between 70%-80% of electric and manual wheelchairs purchased by Americans are manufactured in China. When President Donald Trump imposed a 145% tariff on imported Chinese goods in April 2025, wheelchairs and other durable medical equipment were not exempted.
Last month, a White House summit between Chinese leader Xi Jinping and President Donald Trump resulted in a “30-for-30” framework that cut tariffs on a combined $60 billion worth of nonsensitive goods imported between the two countries. Wheelchairs and other durable medical supplies were not included among those goods.
Days before Trump imposed the 145% tariff on Chinese goods, 10 healthcare organizations signed a letter to U.S. Trade Representative Jamieson Greer warning of possible impending supply chain disruptions and rising prices for dental and medical supplies, particularly for healthcare providers in rural and medically underserved communities.
“We are also concerned that increased costs on medical and dental supplies could impede our ability to improve treatment outcomes, foster innovation, and meet the growing needs of pediatric and adult populations. This could result in longer wait times, reduced access to necessary treatments, and greater financial strain on health care systems that are already under pressure,” the letter said.
Medicare, Medicaid and private insurance providers use fixed reimbursement rates for home medical equipment, although private insurers have more flexibility to negotiate rates with suppliers. Tariff-driven price hikes on products often compel medical suppliers either to absorb the cost increases or to pass them on to patients.
In September 2025, the Trump administration announced that it was investigating the national security implications of imported medical goods, including wheelchairs, to determine whether new tariffs or quotas were needed to incentivize domestic manufacturing.
The American Hospital Association urged the Trump administration to make tariff exemptions for imported medical goods to avoid supply chain disruptions. In a letter to the Commerce Department, the nonprofit Alliance for Aging Research said, “Older adults cannot absorb higher costs or supply disruptions without serious consequences for their health and quality of life.”
In July 2025, Trump signed the One Big Beautiful Bill Act, which cut $1 trillion in funding over a decade from Medicaid. The National Committee to Preserve Social Security and Medicare estimated that up to11 million Americans could lose medical insurance as a result.
Allie Gardner, a senior policy analyst at the Center on Budget and Policy Priorities, told Mother Jones that April that Medicaid cuts would compound the impact of tariffs in making the supplies disabled people need inaccessible. “All of that is likely going to have put pressure on states to make difficult decisions about reassessing eligibility benefits and reimbursement rates, all of which would directly affect people’s coverage and access to care,” Gardner said.